ArcticZymes Technologies ASA
OSE:AZT.OL
40.8 (NOK) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | ArcticZymes Technologies ASA |
Symbool | AZT.OL |
Munteenheid | NOK |
Prijs | 37.5 |
Beurswaarde | 1,907,677,500 |
Dividendpercentage | 0% |
52-weken bereik | 24.2 - 79.4 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Marie Ann Roskrow BSc. (Hons), MBBS (Hons), Ph.D. |
Website | https://arcticzymes.com |
An error occurred while fetching data.
Over ArcticZymes Technologies ASA
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase and derived kits
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (NOK)
Cijfers zijn in miljoenen (NOK)